The meeting, held on 29th and 30th March 2019 at the Examination Schools in Oxford, was attended by 550 scientists and clinicians from 42 countries.
The Mucosal Immunology Group, headed by Professor Holm Uhlig, researches mechanisms of intestinal barrier function and immune regulation in patients with genetic predispositions to develop intestinal inflammation.
Dr Dominik Aschenbrenner from the Mucosal Immunology Group was awarded the first prize at the Falk Foundation Symposium for his poster titled “IBD: From Pathophysiology to Personalized Medicine”.